- A clinical syndrome resulting from excessive secretion of growth hormone (GH).
- GH excess prior to closure of the epiphyseal plates results in gigantism; after epiphyseal plate closure, the result is acromegaly.
- Somatic and metabolic effects of chronic GH hypersecretion are predominantly mediated by high levels of insulin-like growth factor-1 (IGF-1).
- Acromegaly is an uncommon secondary cause of diabetes.
- Excess GH: 1) stimulates gluconeogenesis and lipolysis, causing hyperglycemia and elevated free fatty acid levels; 2) leads to both hepatic and peripheral insulin resistance, with compensatory hyperinsulinemia. Conversely, IGF-1 increases insulin sensitivity. However, in acromegaly, increased IGF-1 levels are unable to overcome the insulin-resistant state caused by GH excess.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 2, 2019
Ball, Douglas. "Acromegaly." Johns Hopkins Diabetes Guide, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547003/2/Acromegaly.
Ball D. Acromegaly. Johns Hopkins Diabetes Guide. 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547003/2/Acromegaly. Accessed June 5, 2023.
Ball, D. (2019). Acromegaly. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547003/2/Acromegaly
Ball D. Acromegaly [Internet]. In: Johns Hopkins Diabetes Guide. ; 2019. [cited 2023 June 05]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547003/2/Acromegaly.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Acromegaly ID - 547003 A1 - Ball,Douglas,M.D. Y1 - 2019/06/02/ BT - Johns Hopkins Diabetes Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547003/2/Acromegaly DB - Johns Hopkins Guides DP - Unbound Medicine ER -